CONSULTANT, DRUG SAFETY PHYSICIAN
Drugs for Neglected Diseases initiative
Posted
Jun 15, 2026
Location
Remote (EU)
Type
Contract
Deadline
⏰ Jul 13, 2026
Mission
What you will drive
- Review clinical trial documents and lead analysis of safety data (adverse events, lab data, vital signs) to update risk management plans.
- Lead the Product Safety Management Team, perform signal detection and evaluation, and ensure documentation of safety assessments.
- Contribute to regulatory reporting (ICSRs, aggregate reports) and collaborate with internal/external committees on safety profile and risk management.
- Stay updated on global pharmacovigilance regulations, participate in capacity building, and support audits/inspections.
Impact
The difference you'll make
This role directly contributes to the development of safe and effective treatments for neglected diseases, ensuring patient safety and enabling access to new therapies for underserved populations worldwide.
Profile
What makes you a great fit
- Physician (MD) with 12+ years overall professional experience including 2-5 years of pharmacovigilance experience in industry.
- Excellent knowledge of clinical development process and ability to manage competing tasks in a fast-paced environment.
- Proficiency in MS Office, MedDRA, WHOART, and working knowledge of safety databases.
- Fluent in English; experience with regulatory interactions and neglected disease populations is advantageous.
Benefits
What's in it for you
Part-time (50%) consultancy position with flexible location (Africa, Europe, Latam). Compensation details not specified.
About
Inside Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative (DNDi) is a nonprofit research and development organization that drives therapeutic innovation from lab bench to patient bedside, advancing treatment candidates for neglected diseases.